Japanese Biotech Stocks

Chugai Pharmaceutical

Market Cap: JP¥10.9t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.3t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Otsuka Holdings

Market Cap: JP¥4.2t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Astellas Pharma

Market Cap: JP¥3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.2t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

Eisai

Market Cap: JP¥1.5t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Ono Pharmaceutical

Market Cap: JP¥801.7b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Santen Pharmaceutical

Market Cap: JP¥536.5b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥297.7b

Manufactures and sells pharmaceuticals in Japan.

Tsumura

Market Cap: JP¥274.6b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥232.7b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Nippon Shinyaku

Market Cap: JP¥223.0b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

PeptiDream

Market Cap: JP¥208.0b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Kissei Pharmaceutical

Market Cap: JP¥184.4b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Towa Pharmaceutical

Market Cap: JP¥146.9b

Manufactures and sale ethical drugs in Japan.

Kaken Pharmaceutical

Market Cap: JP¥144.8b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

GNI Group

Market Cap: JP¥135.4b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Mochida Pharmaceutical

Market Cap: JP¥115.4b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Takara Bio

Market Cap: JP¥112.9b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Zeria Pharmaceutical

Market Cap: JP¥92.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥87.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥72.6b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥67.7b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Fuji Pharma

Market Cap: JP¥38.3b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

3-D Matrix

Market Cap: JP¥37.5b

Develops self-assembling peptide technology in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥37.4b

Manufactures and sells pharmaceutical products worldwide.

Astena Holdings

Market Cap: JP¥21.5b

Manufactures and sells medicine-related products in Japan.

Japan Tissue Engineering

Market Cap: JP¥20.9b

Engages in the regenerative medicine business in Japan.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.7b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

StemRIM

Market Cap: JP¥18.6b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Kidswell Bio

Market Cap: JP¥12.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

CellSource

Market Cap: JP¥11.4b

Engages in the regenerative medicine-related businesses in Japan.

Chordia Therapeutics

Market Cap: JP¥9.6b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

OncoTherapy Science

Market Cap: JP¥8.2b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.